LAUSANNE, Switzerland, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and…
MELBOURNE, Oct 1, 2021 – (ACN Newswire via SEAPRWire.com) – Today, adults living with severe corneal inflammation from DED (dry eye disease) gain access to…
SINGAPORE – Rare cases of heart inflammation have been reported with Covid-19 vaccines that use mRNA technology – namely the Pfizer-BioNTech and Moderna jabs, both…